Recursion to Participate in Upcoming Investor Conferences
Recursion (NASDAQ: RXRX) has announced its participation in the upcoming SVB Leerink 11th Annual Global Healthcare Conference from February 14 to February 18, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Recursion (NASDAQ: RXRX) has announced its participation in the upcoming SVB Leerink 11th Annual Global Healthcare Conference from February 14 to February 18, 2022. The conference will feature webcasts accessible in the investor section of www.Recursion.com.
Recursion is a clinical-stage biotechnology firm that focuses on industrializing drug discovery by decoding biology, leveraging its extensive datasets and advanced machine-learning algorithms.
Details
News Market Reaction – RXRX
The recorded move for RXRX in the trading session of this news was -1.20%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, Feb. 8, 2022 /PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its participation in the following upcoming investor conferences:
- SVB Leerink 11th Annual Global Healthcare Conference — Monday, February 14 through Friday, February 18, 2022
Webcasts may be found in the investor section of the Recursion website at www.Recursion.com.
About Recursion
Recursion is the clinical-stage biotechnology company industrializing drug discovery by decoding biology. Enabling its mission is the Recursion Operating System, a platform built across diverse technologies that continuously expands one of the world's largest proprietary biological and chemical datasets, the Recursion Data Universe. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset the Recursion Map, a collection of hundreds of billions of searchable inferences across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
The company is proudly headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montréal and the San Francisco Bay Area. Learn more at www.Recursion.com, or connect on Twitter and LinkedIn.
Media Contact
Media@Recursion.com
Investor Contact
Investor@Recursion.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/recursion-to-participate-in-upcoming-investor-conferences-301476962.html
SOURCE Recursion
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.